 |
PDBsum entry 1y1u
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1y1u
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Structure of unphosphorylated stat5a
|
|
Structure:
|
 |
Signal transducer and activator of transcription 5a. Chain: a, b, c. Fragment: stat5a core fragment. Synonym: stat5a, mammary gland factor. Engineered: yes
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
3.21Å
|
R-factor:
|
0.269
|
R-free:
|
0.299
|
|
|
Authors:
|
 |
D.Neculai,A.M.Neculai,S.Verrier,K.Straub,K.Klumpp,E.Pfitzner,S.Becker
|
Key ref:
|
 |
D.Neculai
et al.
(2005).
Structure of the unphosphorylated STAT5a dimer.
J Biol Chem,
280,
40782-40787.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Nov-04
|
Release date:
|
04-Oct-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P42230
(STA5A_MOUSE) -
Signal transducer and activator of transcription 5A from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
793 a.a.
544 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
280:40782-40787
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the unphosphorylated STAT5a dimer.
|
|
D.Neculai,
A.M.Neculai,
S.Verrier,
K.Straub,
K.Klumpp,
E.Pfitzner,
S.Becker.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
STAT proteins have the function of signaling from the cell membrane into the
nucleus, where they regulate gene transcription. Latent mammalian STAT proteins
can form dimers in the cytoplasm even before receptor-mediated activation by
specific tyrosine phosphorylation. Here we describe the 3.21-A crystal structure
of an unphosphorylated STAT5a homodimer lacking the N-terminal domain as well as
the C-terminal transactivation domain. The overall structure of this fragment is
very similar to phosphorylated STATs. However, important differences exist in
the dimerization mode. Although the interface between phosphorylated STATs is
mediated by their Src-homology 2 domains, the unphosphorylated STAT5a fragment
dimerizes in a completely different manner via interactions between their
beta-barrel and four-helix bundle domains. The STAT4 N-terminal domain dimer can
be docked onto this STAT5a core fragment dimer based on shape and charge
complementarities. The separation of the dimeric arrangement, taking place upon
activation and nuclear translocation of STAT5a, is demonstrated by fluorescence
resonance energy transfer experiments in living cells.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIGURE 2. The quality of the electron density allows the
identification of intermolecular contacts in the Stat5a dimer.
A, 2 mF[o] - DF[c] electron density map contoured at 2 level
around the 2-fold axis of the dimer. B, the residues involved in
the interactions at the interface are colored according to each
monomer after the color coding from Fig. 1B. For clarity only
some of them have been labeled. Hydrogen bonds are represented
as dashed lines.
|
 |
Figure 3.
FIGURE 3. Docking model of the N-terminal domain dimer
structure of STAT4 onto the dimeric STAT5a core fragment
assuming coincidence of their dyads. A, side view of the
ensemble. An arrow indicates the dyad. Dashed lines symbolize
the missing residues between the C termini of the N-terminal
domains and the N termini of the core domains. The color coding
for the STAT5a dimer is identical to the one used in Fig. 1A,
and the N-terminal domain dimer is colored in cyan. B,
electrostatic potential representations of matched surfaces of
the docking partners. The common 2-fold axis is indicated by an
X, and the complementary surfaces are encircled.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
40782-40787)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Ma,
J.S.Gao,
Y.Guan,
X.Shi,
H.Zhang,
M.K.Ayrapetov,
Z.Zhang,
L.Xu,
Y.M.Hyun,
M.Kim,
S.Zhuang,
and
Y.E.Chin
(2010).
Acetylation modulates prolactin receptor dimerization.
|
| |
Proc Natl Acad Sci U S A,
107,
19314-19319.
|
 |
|
|
|
|
 |
J.Chu,
Z.Zhang,
Y.Zheng,
J.Yang,
L.Qin,
J.Lu,
Z.L.Huang,
S.Zeng,
and
Q.Luo
(2009).
A novel far-red bimolecular fluorescence complementation system that allows for efficient visualization of protein interactions under physiological conditions.
|
| |
Biosens Bioelectron,
25,
234-239.
|
 |
|
|
|
|
 |
P.Bernadó,
Y.Pérez,
J.Blobel,
J.Fernández-Recio,
D.I.Svergun,
and
M.Pons
(2009).
Structural characterization of unphosphorylated STAT5a oligomerization equilibrium in solution by small-angle X-ray scattering.
|
| |
Protein Sci,
18,
716-726.
|
 |
|
|
|
|
 |
T.M.Bernaciak,
J.Zareno,
J.T.Parsons,
and
C.M.Silva
(2009).
A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration.
|
| |
Breast Cancer Res,
11,
R52.
|
 |
|
|
|
|
 |
X.Xu,
M.M.Kasembeli,
X.Jiang,
B.J.Tweardy,
and
D.J.Tweardy
(2009).
Chemical probes that competitively and selectively inhibit Stat3 activation.
|
| |
PLoS ONE,
4,
e4783.
|
 |
|
|
|
|
 |
Y.Watanabe,
M.Ikegawa,
Y.Naruse,
and
M.Tanaka
(2009).
A novel splicing variant form suppresses the activity of full-length signal transducer and activator of transcription 5A.
|
| |
FEBS J,
276,
6312-6323.
|
 |
|
|
|
|
 |
C.Schindler,
and
C.Plumlee
(2008).
Inteferons pen the JAK-STAT pathway.
|
| |
Semin Cell Dev Biol,
19,
311-318.
|
 |
|
|
|
|
 |
F.Seydel,
E.Garrigan,
B.Stutevoss,
N.Belkin,
B.Makadia,
J.Carter,
J.D.Shi,
A.Davoodi-Semiromi,
M.McDuffie,
and
S.A.Litherland
(2008).
GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells.
|
| |
J Autoimmun,
31,
377-384.
|
 |
|
|
|
|
 |
J.S.McMurray
(2008).
Structural basis for the binding of high affinity phosphopeptides to Stat3.
|
| |
Biopolymers,
90,
69-79.
|
 |
|
|
|
|
 |
J.W.Kornfeld,
F.Grebien,
M.A.Kerenyi,
K.Friedbichler,
B.Kovacic,
B.Zankl,
A.Hoelbl,
H.Nivarti,
H.Beug,
V.Sexl,
M.Muller,
L.Kenner,
E.W.Mullner,
F.Gouilleux,
and
R.Moriggl
(2008).
The different functions of Stat5 and chromatin alteration through Stat5 proteins.
|
| |
Front Biosci,
13,
6237-6254.
|
 |
|
|
|
|
 |
L.Hennighausen,
and
G.W.Robinson
(2008).
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.
|
| |
Genes Dev,
22,
711-721.
|
 |
|
|
|
|
 |
Q.Zhu,
and
N.Jing
(2007).
Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3.
|
| |
J Comput Aided Mol Des,
21,
641-648.
|
 |
|
|
|
|
 |
R.G.Rosenfeld,
A.Belgorosky,
C.Camacho-Hubner,
M.O.Savage,
J.M.Wit,
and
V.Hwa
(2007).
Defects in growth hormone receptor signaling.
|
| |
Trends Endocrinol Metab,
18,
134-141.
|
 |
|
|
|
|
 |
C.Mertens,
M.Zhong,
R.Krishnaraj,
W.Zou,
X.Chen,
and
J.E.Darnell
(2006).
Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain.
|
| |
Genes Dev,
20,
3372-3381.
|
 |
|
|
|
|
 |
C.P.Lim,
and
X.Cao
(2006).
Structure, function, and regulation of STAT proteins.
|
| |
Mol Biosyst,
2,
536-550.
|
 |
|
|
|
|
 |
N.C.Reich,
and
L.Liu
(2006).
Tracking STAT nuclear traffic.
|
| |
Nat Rev Immunol,
6,
602-612.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |